Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 2.47K | |||||||||
| Gross profit | -2.47K | |||||||||
| Operating expense | 379.25%285.5K | 139.47%234.13K | 758.63%674.18K | 472.38K | 348.44K | 292.54%59.57K | 1,034.20%97.77K | 78.52K | 15.18K | 8.62K |
| Selling and administrative expenses | 379.25%285.5K | 139.47%234.13K | 758.63%674.18K | --472.38K | --348.44K | 292.54%59.57K | 1,034.20%97.77K | --78.52K | --15.18K | --8.62K |
| -Selling and marketing expense | --89.03K | --75.2K | --89.66K | --67.73K | ---- | ---- | --0 | --0 | ---- | ---- |
| -General and administrative expense | 229.80%196.47K | 62.56%158.93K | 644.45%584.52K | --404.65K | --280.71K | 292.54%59.57K | 1,034.20%97.77K | --78.52K | --15.18K | --8.62K |
| Operating profit | -383.39%-287.97K | -139.47%-234.13K | -758.63%-674.18K | -472.38K | -348.44K | -292.54%-59.57K | -1,034.20%-97.77K | -78.52K | -15.18K | -8.62K |
| Net non-operating interest income (expenses) | 50,822.22%9.13K | 11,731.48%12.56K | 10,697.48%16.85K | -4.49K | -4.44K | 0.00%-18 | -285.71%-108 | -159 | -18 | -28 |
| Non-operating interest income | --10.86K | --13.47K | --17.83K | ---- | ---- | ---- | --0 | --0 | ---- | ---- |
| Non-operating interest expense | 9,500.00%1.73K | 740.74%908 | 514.47%977 | --4.49K | --4.44K | 0.00%18 | 285.71%108 | --159 | --18 | --28 |
| Other net income (expenses) | 2,625.28%57.83K | 38.83K | 27.37K | -757.23K | -745.99K | 86.40%-2.29K | -16.84K | |||
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | 86.40%-2.29K | ---- | ---- | ---16.84K | ---- |
| Special income (charges) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | --57.83K | --38.83K | --27.37K | ---757.23K | ---- | ---- | ---- | ---- | ---- | ---- |
| Income before tax | -257.15%-221.01K | -86.70%-182.73K | -700.70%-629.97K | -1.23M | -1.1M | -93.17%-61.88K | -1,031.78%-97.88K | -78.68K | -32.03K | -8.65K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -257.15%-221.01K | -86.70%-182.73K | -700.70%-629.97K | -1.23M | -1.1M | -93.17%-61.88K | -1,031.78%-97.88K | -78.68K | -32.03K | -8.65K |
| Net income continuous operations | -257.15%-221.01K | -86.70%-182.73K | -700.70%-629.97K | ---1.23M | ---1.1M | -93.17%-61.88K | -1,031.78%-97.88K | ---78.68K | ---32.03K | ---8.65K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -257.15%-221.01K | -86.70%-182.73K | -700.70%-629.97K | -1.23M | -1.1M | -93.17%-61.88K | -1,031.78%-97.88K | -78.68K | -32.03K | -8.65K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -257.15%-221.01K | -86.70%-182.73K | -700.70%-629.97K | -1.23M | -1.1M | -93.17%-61.88K | -1,031.78%-97.88K | -78.68K | -32.03K | -8.65K |
| Diluted earnings per share | -136.18%-0.01 | 0 | -271.47%-0.02 | -0.06 | -0.03 | -93.16%-0.0042 | -1,031.25%-0.0067 | -0.0054 | -0.0022 | -0.0006 |
| Basic earnings per share | -136.18%-0.01 | 0 | -271.47%-0.02 | -0.06 | -0.03 | -93.16%-0.0042 | -1,031.25%-0.0067 | -0.0054 | -0.0022 | -0.0006 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.